Ted Price, Diana Tavares-Ferreira, and Stephanie Shiers discuss how mapping gene expression at the neuronal level provides insight into pain mechanisms and anti-pain drug development.

The death rate was higher among those who experienced the seizures, according to a study conducted during the early days of the pandemic.

Richard Smith will discuss the importance of ionic flux in in utero neuronal development.

A physician and neurobiologist at the Rockefeller University who specialized in addiction research, Kreek was best known for her work on developing the treatment for heroin addiction.

Two out of three people who received noninvasive ultrasound appear to have gained some level of consciousness, according to preliminary trial results.

Autopsy studies have yet to find clear evidence of destructive viral invasion into patients’ brains, pushing researchers to consider alternative explanations of how SARS-CoV-2 causes neurological symptoms.

Connecting the dots between COVID-19 and neurological disorders

Health officials are searching for possible exposures to heavy metals, but no sources of contamination have been identified.

John Connolly and Masataka Nishiga discuss the effects of SARS-CoV-2 on the neurological and cardiovascular systems.

Looking at the future of neurodegeneration research!

Comparing the brain scans of high-impact rugby players with those of athletes in noncontact sports, such as rowing and swimming, revealed tiny, yet significant, differences in the brain’s white matter.

These “coarse-grained” plaques resemble those that clog up the brain’s blood vessels in a different disease, pointing to links between the vascular system and the neurodegenerative disease.

When mice that had suffered a stroke were given blood from a healthy donor, they experienced less tissue and neurological damage.

Functional proteomics detects elevated neuroinflammatory markers in patient plasma and cerebrospinal fluid!

The authors propose that the shots might keep the immune system primed to battle diseases that would otherwise contribute to cognitive decline.

The results are a proof-of-concept that the novel coronavirus can replicate in neurons, but it’s too soon to say whether this occurs in people with COVID-19.

SARS-CoV-2 generally attacks the lungs, but researchers are also stressing its effects on the brain in a fraction of patients.

The cell conversion strategy restores neurons and motor functions lost as a result of an induced Parkinson’s-like illness in the animals.

Experts will explore how RNAi mechanisms can modulate gene expression for the treatment of neurodegenerative diseases and how new methods for their use are being developed.